2021 annual financial data
Neumora Therapeutics, Inc. 2021 Operating cash flow
Neumora Therapeutics, Inc. 2021 operating cash flow with verified reported valu…
Direct answer
Operating cash flow was -75,420,000 USD.
Operating income was -237,323,000 USD and net income was -237,312,000 USD.
Operating cash flow was -75,420,000 USD.
Get free Neumora Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -237,323,000 USD
- Net income
- -237,312,000 USD
- Operating cash flow
- -75,420,000 USD